Meloxicam Zentiva

Meloxicam, the active ingredient in Meloxicam Zentiva, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for systemic use. It is indicated for the relief of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain in adult patients. GNH USA supplies Meloxicam Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal disorders. - Osteoarthritis: alleviates joint pain and improves functional mobility. - Rheumatoid arthritis: decreases joint inflammation and slows disease‑related damage. - Ankylosing spondylitis: reduces spinal stiffness and pain. - Acute pain: provides rapid relief of moderate to severe pain from injuries or postoperative states.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache or dizziness. - Diarrhea or constipation. - Mild skin rash or itching. - Peripheral edema.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Hepatic injury presenting as jaundice or elevated liver enzymes. - Severe skin reactions including Stevens‑Johnson syndrome. - Renal impairment or acute kidney injury. - Hematologic abnormalities such as thrombocytopenia or anemia.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events. - Cardiovascular risk assessment: consider underlying heart disease before use. - Renal function monitoring: adjust therapy in patients with impaired kidney function. - Use the lowest effective dose for the shortest duration needed. - Avoid use in the third trimester of pregnancy due to fetal risk. - Review concomitant use of other NSAIDs, anticoagulants, or corticosteroids. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Meloxicam may interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Warfarin or other anticoagulants: increased risk of bleeding. - Lithium: elevated lithium levels leading to toxicity. - Methotrexate: reduced clearance and heightened toxicity.

Moderate Interactions (Monitor Closely): - Diuretics or ACE inhibitors/ARBs: possible reduction in renal function. - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal and cardiovascular adverse effects.